Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K041683
    Date Cleared
    2004-08-27

    (67 days)

    Product Code
    Regulation Number
    876.5820
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    B. BRAUN BICARBONATE DIALYSATE

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    B. Braun Bicarbonate Dialysate is indicated for use with renal replacement therapy systems that utilize sterile bicarbonate dialysate.

    Device Description

    The B. Braun Bicarbonate Dialysate Solutions are a family of sterile, non-pyrogenic, bicarbonate dialysate solutions. The solutions will be provided in flexible two-chamber bags, with bicarbonate solution in one chamber and electrolyte solution in the other chamber. The chambers are separated by a peel seam. The 5,000 mL ready-to-use solution is obtained by pressing on the small chamber of the bag until the peel seam opens, and then rocking the bag back and forth to mix the contents.

    AI/ML Overview

    The provided text describes a 510(k) premarket notification for a medical device: "B. Braun Bicarbonate Dialysate." However, it does not contain any information about acceptance criteria, device performance testing, or a study that proves the device meets such criteria.

    The document is a regulatory submission for premarket clearance and focuses on:

    • Device Identification: Manufacturer, device name, common name, classification, and product code.
    • Predicate Device: Gambro PrismaSate Dialysis Solutions for Continuous Renal Replacement Therapy (K013448).
    • Description: Physical characteristics of the device (sterile, non-pyrogenic, bicarbonate dialysate solutions in a two-chamber flexible bag).
    • Intended Use: Indicated for use with renal replacement therapy systems that utilize sterile bicarbonate dialysate.
    • Substantial Equivalence Claim: The B. Braun Bicarbonate Dialysate is presented as substantially equivalent to the predicate device based on similar composition range, container/closure system, and indications for use.
    • FDA Correspondence: An FDA letter confirming the review of the 510(k) and a determination of substantial equivalence (assuming the indications for use are met).
    • Indications for Use Statement: A separate page specifically stating the intended use as "for use with renal replacement therapy systems that utilize sterile bicarbonate dialysate."

    Therefore, I cannot extract the requested information (acceptance criteria, device performance, study details, sample sizes, ground truth establishment, expert qualifications, etc.) from the provided text, as this type of information is not present. This document is not a study report or a design verification and validation document.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1